D. Euan MacIntyre

10.4k citations

160 papers · 9.2k · 1 hit paper · h-index 46

Impact in

Endocrine and Autonomic Systems top 0.2%
- Regulation of Appetite and Obesity
Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology

Papers in

Hematology 51
- Platelet Disorders and Treatments 51
Endocrine and Autonomic Systems 23
- Regulation of Appetite and Obesity 15

Co-authors: John L. Gordon (32 shared papers)Jeremy D. Pearson (2 shared papers)Michael J. Forrest (13 shared papers)Catherine Abbadie (4 shared papers)Margaret A. Cascieri (24 shared papers)Archibald McNicol (5 shared papers)Edwin W. Salzman (15 shared papers)W K Pollock (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (28 papers)Journal of Medicinal Chemistry (11 papers)Thrombosis and Haemostasis (9 papers)Biochemical Journal (6 papers)Thrombosis Research (6 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

D. Euan MacIntyre

153 papers receiving 8.5k citations

D. Euan MacIntyre's Hit Papers

align trajectories log scale

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1) 2005 · 655 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2005 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by D. Euan MacIntyre

Since Specialization

Citations

This map shows the geographic impact of D. Euan MacIntyre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Euan MacIntyre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Euan MacIntyre more than expected).

Fields of papers citing papers by D. Euan MacIntyre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Euan MacIntyre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Euan MacIntyre. The network helps show where D. Euan MacIntyre may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Euan MacIntyre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Euan MacIntyre Line = papers co-authored together D. Euan MacIntyre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass Nature Genetics ·Airu S. Chen, Donald J. Marsh, Myrna E. Trumbauer, Easter G. Frazier, Xiao-Ming Guan, Hong Yu, Charles I Rosenblum, Aurawan Vongs	2000	780
2	The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1) Proceedings of the National Academy of Sciences ·Margarita M. Garcia-Calvo, JeanMarie Lisnock, Herbert G. Bull, Brian E. Hawes, Duane A. Burnett, Matthew P. Braun, James H. Crona, Harry R. Davis Hit paper breakdown →	2005	655
3	Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 Proceedings of the National Academy of Sciences ·Catherine Abbadie, Jill Ann Lindia, Anne Marie Cumiskey, Larry Peterson, John S. Mudgett, Ellen Kahn Bayne, Julie A. DeMartino, D. Euan MacIntyre	2003	527
4	Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism Proceedings of the National Academy of Sciences ·Donald J. Marsh, Drew T. Weingarth, Dawn E. Novi, Howard Y. Chen, Myrna E. Trumbauer, Airu S. Chen, Xiao-Ming Guan, Michael M. Jiang	2002	483
5	Localisation and stimulation of prostacyclin production in vascular cells Nature ·D. Euan MacIntyre, Jeremy D. Pearson, John L. Gordon	1978	315
6	L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor Canadian Journal of Physiology and Pharmacology ·John W. Gillard, A W Ford‐Hutchinson, Chi-Chung Chan, Stella E. Charleson, Aidan Foster, Réjean Fortin, Serge Léger, C. S. McFarlane	1989	296
7	A role for the melanocortin 4 receptor in sexual function Proceedings of the National Academy of Sciences ·Lex H.T. Van der Ploeg, William J. Martin, Andrew D. Howard, Ravi P. Nargund, Christopher P. Austin, Xiao-Ming Guan, Jennifer E. Drisko, Doreen E. Cashen	2002	269
8	Contribution of the tetrodotoxin-resistant voltage-gated sodium channel Na V 1.9 to sensory transmission and nociceptive behavior Proceedings of the National Academy of Sciences ·Birgit T. Priest, Beth Ann Murphy, Jill Ann Lindia, Catherine Abbadie, Amy M. Ritter, Paul Liberator, Leslie M. Iyer, Shera F. Kash	2005	242
9	Role of the melanocortin-4 receptor in metabolic rate and food intake in mice Transgenic Research ·Airu S. Chen, Joseph M. Metzger, Myrna E. Trumbauer, Xiao-Ming Guan, Hong Yu, Easter G. Frazier, Donald J. Marsh, Michael J. Forrest	2000	220
10	Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets Neuropharmacology ·F.D. Tattersall, Wayne Rycroft, B. Francis, Kevin J. Merchant, Angus M. MacLeod, Tammy Ladduwahetty, Linda E. Keown, Christopher J. Swain	1996	193
11	Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides Bioorganic & Medicinal Chemistry Letters ·Linda L. Brockunier, Emma R. Parmee, Hyun Ok, Mari R. Candelore, Margaret A. Cascieri, Lawrence F. Colwell, Liping Deng, William P. Feeney	2000	185
12	Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist Journal of Medicinal Chemistry ·Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Paul E. Finke, Margaret A. Cascieri, Sharon J. Sadowski, Elżbieta Ber, Gary G. Chicchi	1998	178
13	Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist Journal of Medicinal Chemistry ·Iyassu K. Sebhat, William J. Martin, Zhixiong Ye, Khaled Barakat, Ralph T. Mosley, Raman K. Bakshi, Brenda L. Palucki, Tanya MacNeil	2002	166
14	Tumour‐promoting phorbol esters inhibit agonist‐induced phosphatidate formation and Ca2+ flux in human platelets FEBS Letters ·D. Euan MacIntyre, Archibald McNicol, Alan H. Drummond	1985	164
15	Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats European Journal of Pharmacology ·Lauren P. Shearman, Ramon E. Camacho, D. Sloan Stribling, Dan Zhou, Maria A. Bednarek, Donna L. Hreniuk, Scott D. Feighner, Carina P. Tan	2003	155
16	Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. The Journal of Experimental Medicine ·Roger D. Meurer, Gail Van Riper, William P. Feeney, D. F. Hora, Marty S. Springer, D. Euan MacIntyre, Hugh Rosen +1 other	1993	148
17	LIPID DOMAINS IN MEMBRANES* Annals of the New York Academy of Sciences ·Morris J. Karnovsky, Alan M. Kleinfeld, Richard L. Hoover, Eliezar A. Dawidowicz, D. Euan MacIntyre, Edwin W. Salzman, Richard D. Klausner	1982	146
18	The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets Neuropharmacology ·F.D. Tattersall, Wayne Rycroft, Michael J. Cumberbatch, Glenn S. Mason, Spencer J. Tye, J.J. Hale, Sander G. Mills, Paul E. Finke	2000	125
19	Ghrelin Neutralization by a Ribonucleic Acid-SPM Ameliorates Obesity in Diet-Induced Obese Mice Endocrinology ·Lauren P. Shearman, Sheng-Ping Wang, Steffen Helmling, D. Sloan Stribling, Paul Mazur, Lan Ge, Sven Klußmann, D. Euan MacIntyre	2005	125
20	Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses Neuroscience ·Joseph P. Menetski, Shruti Mistry, Min Lu, John S. Mudgett, Richard M. Ransohoff, Julie A. DeMartino, D. Euan MacIntyre, Catherine Abbadie	2007	109

About D. Euan MacIntyre

D. Euan MacIntyre is a scholar working on Hematology, Endocrine and Autonomic Systems, Pharmacology, Biochemistry and Molecular Biology, having authored 160 papers that have together received 9.2k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (51 papers), Inflammatory mediators and NSAID effects (23 papers), Receptor Mechanisms and Signaling (20 papers), Regulation of Appetite and Obesity (15 papers), Neuropeptides and Animal Physiology (15 papers), Synthesis and biological activity (15 papers), Eicosanoids and Hypertension Pharmacology (13 papers) and Protein Kinase Regulation and GTPase Signaling (8 papers). The work is most often cited by research in Endocrine and Autonomic Systems (1.8k citations), Biochemistry (565 citations), Hematology (910 citations), Pharmacology (897 citations) and Physiology (1.2k citations). D. Euan MacIntyre has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John L. Gordon, Jeremy D. Pearson, Michael J. Forrest, Catherine Abbadie, Margaret A. Cascieri, Archibald McNicol, Edwin W. Salzman, W K Pollock, William J. Martin and Jill Ann Lindia. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Thrombosis and Haemostasis, Biochemical Journal and Thrombosis Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

D. Euan MacIntyre

Impact in

Papers in i

In The Last Decade

D. Euan MacIntyre

D. Euan MacIntyre's Hit Papers

Peers

Countries citing papers authored by D. Euan MacIntyre

Fields of papers citing papers by D. Euan MacIntyre

All Works

About D. Euan MacIntyre

Explore authors with similar magnitude of impact

Papers in